What's new
Everything that changed here, newest first: research, patents, portfolio works, books, and the site itself.
September 2026
NewResearch & IP
The Executive Narrative Without KPI Tiles
Leadership reporting written as prose that states the causal claim, with measures, believed drivers and confidence in support, and an explicit section on what remains unknown.
NewResearch & IP
The Labor Curve
A rules-based operation has no mechanism to break the link between panel size and headcount. An AI-native one does, but the first two quarters of a migration cost more, not less, and the curve only bends where shadow-mode agreement supports widening autonomy.
NewResearch & IP
The Patient Story Replaces the Chart Page
A narrative generated around the question currently being asked, with timeline lanes that draw missing data as missing, and explicit reasoning about which care program actually fits.
NewResearch & IP
The phone is part of the device
Architectures where a smartphone or wearable is a component of the medical device, not a companion screen. It removes hardware and adds obligations, and the trade is only worth making with both sides written down.
NewResearch & IP
Typed Utterances and Honest Uncertainty
Every statement the system makes carries a type: observation, inference, recommendation, automated action, human-approved action, unresolved uncertainty, or prohibited action. Missing data is rendered as missing, and standing constraints hold at every autonomy level.
NewResearch & IP
What is actually medically specialized
Separate component availability from medical performance. The part being cheap says nothing about calibration, accuracy, reliability, safety, cybersecurity, manufacturing controls, or evidence. Confusing the two is how consumer-grade thinking hurts patients.
NewResearch & IP
What This Line of Research Does Not Claim
No proven outcome improvement without a connected analytics warehouse; disagreement concentrating in recent medication changes; projections that remain projections. The limits stated plainly, in one place.
NewResearch & IP
Where the device thesis should be rejected
The rejection criteria, written before we get attached to anything. Novel materials, exotic sensing physics, sterile manufacturing, life-sustaining risk, and trial-scale evidence requirements all put a category outside this thesis.
NewNetwork
Network finds who matters to a thesis, why now, and whether someone else is already doing the work
Intellectual Frontiers Network is the intelligence layer across the firm, with pages on how it works and a way to ask it a question.
NewCapital
The Care Delivery funds are described: one active under $1M, one in formation
Care Delivery Fund I is an active fund under $1M that incubates ten companies and programs, and Fund II is in formation, explored at $25M to $50M.
NewResearch & IP
Adoption latency score
Estimate the time from first evidence to first use, repeat use, and routine use without pretending institutional clocks disappear.
NewResearch & IP
Adversarial design-around report
Give a capable future competitor the customer outcome and ask for credible routes around the proposed boundary.
NewResearch & IP
AI changes the configuration economics
Specialized SaaS won largely because configuring general-purpose platforms was expensive. If AI collapses that cost, the reason for the historical result stops applying.
NewResearch & IP
AI compression test
Assume capable AI makes ordinary reasoning and software cheap, then identify how much of the claimed advantage disappears.
NewResearch & IP
AI resilience score
Test what remains scarce after a competitor gains better models, tools, and engineering capacity.
NewResearch & IP
Alpha to Operate dependency and rights map
Map the rights owned and the rights still needed to build, sell, deploy, manufacture, distribute, or license a product wedge.
NewResearch & IP
Alpha to Rights decision memo
Match each scarce asset to the narrowest control that can protect and commercialize it.
NewResearch & IP
An AI credential
Represent trust as evidence about a narrow capability, approved sources, authority, incidents, and recertification.
NewResearch & IP
Authority progression and recertification
Increase authority only after evidence and reduce it automatically when material conditions change.
NewResearch & IP
Burden Payer and Burden Imposer matrix
Show who requires work, who performs it, who pays, who benefits, who waits, and who can change it.